Who Qualifies for GLP-1 Weight-Loss Medication? An India Guide

Editorial notice: This article is general educational content about prescription weight-management treatments available in India. It is not medical advice, not a recommendation to use any specific medication, and not a promotion of any brand. NuvaHealth does not sell, stock, or dispense any medication. All treatment decisions must be made in a private consultation with a qualified doctor who has reviewed your complete medical history. Prescription medicines discussed here are Schedule H drugs and are available only with a valid prescription from a licensed pharmacy.

GLP-1 Medications Are Not for Everyone

One of the biggest misunderstandings about GLP-1 weight-loss medications — semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro) — is that anyone who wants to lose a few kilograms can simply take them. They are not lifestyle products. They are prescription treatments for a medical condition: obesity and its related health risks.

That distinction matters. These medications are powerful, they have real side effects, they are expensive, and they generally need to be continued long-term. Prescribing them appropriately means matching them to people for whom the health benefit clearly outweighs the cost and the risk. So who, specifically, qualifies?

The Standard BMI Criteria

Internationally, eligibility for GLP-1 weight-management medication follows two well-defined pathways based on body mass index (BMI):

• Pathway 1 — a BMI of 30 or above. A BMI of 30 or higher is the clinical threshold for obesity. People in this range generally qualify on weight alone.
• Pathway 2 — a BMI of 27 or above, plus a weight-related health condition. People classed as overweight rather than obese can still qualify if excess weight is already harming their health.

These thresholds were set largely from studies in Western populations. For Indians, they need an important adjustment.

Why the BMI Cutoffs Are Different for Indians

South Asians develop the metabolic complications of excess weight — insulin resistance, raised blood sugar, fatty liver, cardiovascular risk — at lower BMIs than Europeans. Indians tend to carry more visceral fat, the dangerous fat around the internal organs, at any given BMI.

Because of this, Indian and other Asian guidelines use lower cutoffs: overweight begins around a BMI of 23, and obesity around 25, rather than 25 and 30. The practical consequence is that an Indian adult can carry a clinically meaningful weight problem at a BMI that would look normal on a Western chart. A doctor assessing an Indian patient for GLP-1 eligibility therefore considers these lower, ethnicity-appropriate thresholds — alongside waist circumference — rather than applying Western numbers blindly. Our complete BMI guide for Indians explains these cutoffs in detail.

The Weight-Related Conditions That Lower the Threshold

Under the second pathway, a person with a lower BMI can still be an appropriate candidate if they already have a condition driven or worsened by excess weight. These conditions include:

• Type 2 diabetes or prediabetes
• High blood pressure
• High cholesterol or triglycerides
• Obstructive sleep apnoea
• Cardiovascular disease
• Fatty liver disease
• Weight-related osteoarthritis
• PCOS, which is closely linked to insulin resistance

The logic is straightforward: if excess weight is already causing measurable harm, the threshold for treating it medically is lower.

Who Should NOT Take GLP-1 Medications

Eligibility is also about exclusions. GLP-1 medications are generally not appropriate for:

• People who are pregnant, planning pregnancy, or breastfeeding
• Anyone with a personal or family history of medullary thyroid carcinoma or the MEN-2 syndrome
• People with a history of pancreatitis
• People with certain severe gastrointestinal conditions
• People with a history of certain eating disorders, who need specialist care first
• People seeking only small, cosmetic weight loss, where the risk and cost are not justified

This is why these drugs cannot safely be self-prescribed: only a proper medical history reveals whether one of these exclusions applies.

It Is Not Just About BMI

BMI and conditions are the starting point, not the whole assessment. Before prescribing, a careful doctor also evaluates:

1. Your full medical history and current medicines, to check for interactions and contraindications
2. Blood tests — blood sugar, liver and kidney function, and other markers
3. Waist circumference and body composition, not weight alone
4. What you have already tried, and why it did or did not work
5. Whether you can sustain the treatment — cost, follow-up, and the long-term nature of the therapy
6. Your goals and expectations, to ensure they are realistic and safe

Two people with the same BMI can receive completely different recommendations once these factors are weighed.

What If You Do Not Qualify — Yet?

If a doctor concludes that medication is not right for you, that is useful information, not a dead end. It often means your weight can be addressed effectively through structured nutrition, activity, sleep and muscle-building — the foundations that work for everyone, with or without medication. Our guides to why diets fail and the Indian protein paradox are good places to start. Eligibility can also change over time, and a doctor can reassess.

Find Out If You Qualify — Talk to a Doctor on NuvaHealth

The only way to know whether GLP-1 medication is appropriate for you is a proper medical assessment — not an online quiz or a pharmacy counter. NuvaHealth connects you with licensed Indian doctors who will review your BMI, waist measurement, medical history and goals, and give you an honest answer: whether medication has a role, and what the right next step is either way.

Start your assessment on NuvaHealth today and get a clear, qualified answer about your eligibility.